FOS and cancer: Although the study did not perform large-scale systemic screening of all pathways related EMT, based on our findings, we suggest that pharmacological inhibition of key drivers such as the AP-1 complex could mitigate cancer cell invasion, providing a rationale for exploring these pathways as therapeutic targets.